Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
about
Update in lung cancer and mesothelioma 2012Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS)Surgical treatment of early-stage non-small-cell lung cancer.Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma.Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.Using the CT features to differentiate invasive pulmonary adenocarcinoma from pre-invasive lesion appearing as pure or mixed ground-glass nodulesNoninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.Clinical outcomes of patients with metachronous second primary lung adenocarcinomas.Non-small cell lung cancer: the new T1 categories.Preoperative nomogram for identifying invasive pulmonary adenocarcinoma in patients with pure ground-glass nodule: A multi-institutional study.Pathologic classification of adenocarcinoma of lung.2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.Novel treatment options in stage I non-small-cell lung cancer.Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.Novel teatment options in early-stage non-small-cell lung cancer.Diagnosis of lung adenocarcinoma in situ and minimally invasive adenocarcinoma from intraoperative frozen sections: an analysis of 136 cases.Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinomaIntegrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.Solitary ground-glass opacity nodules of stage IA pulmonary adenocarcinoma: combination of 18F-FDG PET/CT and high-resolution computed tomography features to predict invasive adenocarcinoma.How to deal with subcentimeter lung cancer: a moving target!Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.Clinical predictor of pre- or minimally invasive pulmonary adenocarcinoma: possibility of sub-classification of clinical T1a.Surgery compared to stereotactic body radiation therapy for early-stage non-small cell lung cancer: better, equivalent or worse?Analysis of pulmonary pure ground-glass nodule in enhanced dual energy CT imaging for predicting invasive adenocarcinoma: comparing with conventional thin-section CT imaging.Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.An Immunohistochemical Study of Anaplastic Lymphoma Kinase and Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Carcinoma.Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma.Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma.Second primary non-small-cell lung cancer: implications of the new adenocarcinoma classification in the challenging decision of the best surgical strategy.HRCT features distinguishing pre-invasive from invasive pulmonary adenocarcinomas appearing as ground-glass nodules.[Issues Relevant to Surgical Intervention in 'Tiny' Non-small Cell Lung Cancer Detected by 'Lung Screening'--Orientation, Lung Resection and Lymph Node Resection].The ground glass opacity component can be eliminated from the T-factor assessment of lung adenocarcinoma.Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression.[The Initial Experience of Video-assisted Thoracic Surgery Segmentectomy for Early Stage Lung Cancer].
P2860
Q24619675-C79BF3DF-62D3-4D5D-8802-62F33891338AQ27009370-195C37DB-ED44-4706-A019-4E4C9AFA82F8Q33699085-CA5EB7B0-BC8F-4500-B420-DF7F42ED03C2Q34623141-9D718C64-BAFA-4FCA-AA3B-3E3B4011B585Q35176964-A738015D-3DC0-465E-B5F0-8148090D7CB2Q36128556-75CF3FEF-AAB7-42AC-A0B1-958B48636DFEQ36550887-C3C76014-0F65-4A40-85D0-D90446DD58DBQ36685679-DA76BC14-9CFC-4FE6-B24A-8D7396A7F370Q37587201-5A4B89DD-E341-4A5D-B55E-ACFFF481492FQ37664741-E2C4F9BE-B632-4D21-B2B2-39F7DA430611Q37725598-60589310-A391-497A-8FF6-3A4EE6C84200Q38134347-6BBA247A-95AB-4B78-AD63-B33FC9083C9AQ38190426-B0DDC281-A562-4581-A339-BC7187418528Q38220335-890E14FD-8010-4039-839D-1F0938868167Q38386941-FB939C99-46F5-46AD-AFF2-D37600DD31FDQ38555895-6436FEE7-D83D-4B08-972F-476114C37703Q39769769-29DACC2B-48D8-4D29-8FD7-8601769607FCQ41340974-5260FC48-A9B0-4C6D-9002-5CB7FCFF4442Q41513462-F2D66465-9F5F-4B68-97C1-FB4441541B91Q42290124-6404DFB9-EFC6-405C-9B48-805D2AFA2568Q42369334-7F6BEECB-883D-4A6A-BFEC-24B3F511A11EQ42393298-14E5A3F2-9F47-4A22-BB7C-1DCC08EAB87BQ45373204-67FA1366-BA26-4E85-9E47-AE80556DF825Q47106372-EB0BB772-CA45-4FFD-A027-9127764CE5A0Q47193573-2EC38A3D-725B-4C97-99FA-BBDAF9A4CC9AQ47643364-57A92462-61B6-4193-B200-7BA67103C698Q47644346-06A32AEC-8A01-4006-B46E-0D2E351A4C2BQ47986975-5252947D-1B69-455A-9C2F-2D976012983AQ49604721-EA59CFA5-785F-4E7D-BE6D-9FBC4B55A90EQ51464905-BAD72833-D628-48B7-B3E5-53A6EC6692EFQ51650847-6694C1ED-B984-4AD1-8292-FA3EC1F23E21Q51785576-971F6F58-5704-45E6-9C00-6AA8B207BA7EQ52986920-B1FC2EBC-EA2A-48A2-B75B-42B86FD69B3EQ53080294-48B6FE3F-41CA-4C93-B18E-22BA843B7CCBQ53137873-8CDF9B24-563F-49C3-A4AE-A2A7998FE080Q54980290-6989CEAB-8A84-4740-9C19-5378C6CD02D7Q55446967-6D24621A-47BB-412D-ABCA-136C78498CCE
P2860
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@ast
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@en
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@nl
type
label
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@ast
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@en
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@nl
prefLabel
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@ast
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@en
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@nl
P2093
P3181
P1476
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
@en
P2093
E Brambilla
P E Van Schil
W D Travis
P304
P3181
P356
10.1183/09031936.00027511
P407
P577
2012-02-01T00:00:00Z